These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1783249

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study.
    Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hédon B, Marès P.
    Thromb Haemost; 1997 Jun; 77(6):1096-103. PubMed ID: 9241739
    [Abstract] [Full Text] [Related]

  • 23. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion.
    Keber D, Stegnar M, Kluft C.
    Thromb Haemost; 1990 Feb 19; 63(1):72-5. PubMed ID: 2111049
    [Abstract] [Full Text] [Related]

  • 27. Fibrinolysis and spinal injury. Relationship to post-traumatic deep vein thrombosis.
    Petäjä J, Myllynen P, Rokkanen P, Nokelainen M.
    Acta Chir Scand; 1989 Feb 19; 155(4-5):241-6. PubMed ID: 2508383
    [Abstract] [Full Text] [Related]

  • 28. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
    Speidl WS, Zeiner A, Nikfardjam M, Geppert A, Jordanova N, Niessner A, Zorn G, Maurer G, Schreiber W, Wojta J, Huber K.
    J Am Coll Cardiol; 2005 Jan 04; 45(1):30-4. PubMed ID: 15629369
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Altered endothelial function following the Fontan procedure.
    Binotto MA, Maeda NY, Lopes AA.
    Cardiol Young; 2008 Feb 04; 18(1):70-4. PubMed ID: 18093358
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR.
    J Lab Clin Med; 1987 Jun 04; 109(6):665-71. PubMed ID: 3108431
    [Abstract] [Full Text] [Related]

  • 32. [Thromboembolic disease and anomalies of fibrinolysis].
    Juhan-Vague I, Aillaud MF, Valadier J, Alessi MC, Serradimigni A.
    Ann Med Interne (Paris); 1986 Jun 04; 137(6):471-4. PubMed ID: 3101564
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma.
    Brommer EJ, Verheijen JH, Chang GT, Rijken DC.
    Thromb Haemost; 1984 Oct 31; 52(2):154-6. PubMed ID: 6441302
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Oct 31; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 38. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.
    Sultan Y, Harris A, Strauch G, Venot A, De Lauture D.
    J Lab Clin Med; 1988 Jun 31; 111(6):645-53. PubMed ID: 3131470
    [Abstract] [Full Text] [Related]

  • 39. Dyslipidemias and fibrinolysis.
    Puccetti L, Bruni F, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, Auteri A.
    Ital Heart J; 2002 Oct 31; 3(10):579-86. PubMed ID: 12478815
    [Abstract] [Full Text] [Related]

  • 40. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
    Levesque H, Borg JY, Cailleux N, Vasse M, Daliphard S, Gancel A, Monconduit M, Courtois H.
    Eur J Med; 1993 May 31; 2(5):287-8. PubMed ID: 8252160
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.